Delivery Order SPE2DB20D2104-SPE2DB23FT21P
- Not listed
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, valued at $1,102.08. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has a ceiling value of $1,102.08 and is a delivery order under an Indefinite Delivery Contract (IDC) held...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Spiriva Respimat 2.5 mcg inhalers. The $3,578.37 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that supports U.S. military healthcare. The contract has an ultimate completion date of September 14, 2022 and was awarded on September 13, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The fixed-price delivery order, valued at $2,705.64, has a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of Spiriva Respimat 1.25 mcg inhalers. The contract has a ceiling value of $1,377.08 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award, valued at $1,295.08, is a firm fixed price delivery order for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract has a ceiling value of $3,122.70 and runs through January 19, 2023. It is a firm fixed-price, delivery order contract type. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a ceiling value of $2,742.13 and a completion date of December 7, 2023. This is a firm fixed-price delivery order contract, and no set-aside designation was used. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a ceiling value of $2,176.55 and a completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a ceiling value of $7,669.16. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024, with a delivery order contract type and firm fixed pricing. The contract has an ultimate completion date of August 23, 2024 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,223.51 and is a Firm Fixed Price Delivery Order. It has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT21PDelivery Order
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalers to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $7,112.62. The contract has a firm fixed price and is set to be completed by April 25, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 4/24/23 |